Microdosed Tirzepatide

Dual-action on the GLP-1 and GIP receptor pathways, at a micro dose. Your provider will tell you whether that is the right starting point for you. 10/5 mg/ml, up to 2.5mg weekly, as prescribed by clinician if appropriate.

✓Dual-action on the GLP-1 and GIP receptor pathways

✓Studied for body composition and insulin sensitivity

✓Lower overall medication exposure at a micro dose

✓Pre-measured, labeled in milligrams. No mixing, no math

✓Prescribed by a US clinician in your state if appropriate

1. CHOOSE YOUR FORM

Tablet

Daily, needle-free

Subcutaneous Injection

Weekly injection

2. CHOOSE YOUR PLAN

Monthly

Month to month · cancel anytime

$245/mo$295/mo

$245 billed monthly

3-MonthMost chosen

Billed quarterly · 3-month supply

$221/mo$271/mo

$661.50 billed quarterly · Save $74

AnnualBest value

Billed annually · 12-month supply

$196/mo$246/mo

$2,352 billed up front · Save $588

Prices do not include lab work. You're not charged until a licensed provider reviews your intake and approves treatment.

Start my intake

POTENCY

Injection

1 mg/mL · up to 0.25 mg weekly, as prescribed by your clinician if appropriate

Tablet

4 mg tablets, as prescribed by your clinician if appropriate

IMPORTANT SAFETY INFORMATION · COMPOUNDED TIRZEPATIDE+

Important Safety Information: Tirzepatide may cause serious side effects, including a potential risk of thyroid C-cell tumors. Do not use tirzepatide if you or a family member has had medullary thyroid carcinoma (MTC), if you have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), or if you have had a serious allergic reaction to tirzepatide.

⟦Serious and common side effects, drug interactions, and pregnancy guidance for tirzepatide — paste the rest of the approved copy here.⟧

Compounded medication: Compounded tirzepatide is prescribed when clinically appropriate and prepared by a state-licensed compounding pharmacy. Compounded medications are not FDA-approved and are not reviewed by the FDA for safety, effectiveness, or manufacturing quality. FDA-approved medications containing tirzepatide are commercially available.

Any information provided is for informational purposes only and is not medical advice. All patients must consult with a healthcare provider before any medication is prescribed or dispensed. Compounded drug products are not FDA-approved, and the FDA does not evaluate their safety, effectiveness, or quality.